Table 3.
Associations between prior pain exposure, prior morphine exposure and illness severity with facial and autonomic responses to heel lance and cortisol response to a series of nursing procedures
| Illness severity (snap II day I) | Pain exposure (number of skin breaking procedures) birth to 32 weeks | Morphine exposure (daily average mg/kg×days) birth to 32 weeks | Mechanical ventilation (days) | |
|---|---|---|---|---|
| Infants born ≤ 28 weeks GAa | ||||
| Facial (lance) n = 29 | —0.26 | —0.44* | —0.42* | —0.19 |
| HR (baseline to lance) n = 28 | —0.24 | —0.09 | —0.15 | 0.05 |
| Low frequency (baseline to lance) n = 28 | —0.02 | —0.28 | 0.05 | —0.31 |
| High frequency (baseline to lance) n = 28 | —0.25 | —0.19 | —0.34 | —0.27 |
| Cortisol (clustered care) n = 23 | —0.17 | —0.50* | —0.26 | —0.37 |
| Infants born 29—32 weeks GAb | ||||
| Facial (lance) n = 43 | 0.16 | 0.05 | 0.19 | —0.09 |
| HR (baseline to lance) n = 45 | —0.06 | 0.09 | 0.05 | 0.03 |
| Low frequency (baseline to lance) n = 45 | —0.36* | —0.10 | —0.11 | 0.07 |
| High frequency (baseline to lance) n = 45 | —0.13 | —0.11 | —0.15 | 0.15 |
| Cortisol (clustered care) n = 45 | 0.19 | 0.10 | —0.04 | 0.12 |
P < 0.05
n = 30 ELGA infants had one or more outcomes (facial, cardiac, cortisol).
n = 57 VLGA infants had one or more outcomes (facial, cardiac, cortisol).